1. |
Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy, 2020, 52(2): 127-149.
|
2. |
Shekelle PG, Woolf SH, Eccles M, et al. Developing clinical guidelines. West J Med, 1999, 170(6): 348-351.
|
3. |
Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc, 1991, 37(3): 383-393.
|
4. |
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut, 2013, 62(1): 102-111.
|
5. |
Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol, 2007, 102(8): 1781-1788.
|
6. |
Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc, 2015, 81(1): 143-149.
|
7. |
Ding X, Zhang F, Wang Y. Risk factors for post-ERCP pancreatitis: a systematic review and meta-analysis. Surgeon, 2015, 13(4): 218-229.
|
8. |
El Nakeeb A, El Hanafy E, Salah T, et al. Post-endoscopic retrograde cholangiopancreatography pancreatitis: Risk factors and predictors of severity. World J Gastrointest Endosc, 2016, 8(19): 709-715.
|
9. |
Tang Z, Yang Y, Yang Z, et al. Early precut sphincterotomy does not increase the risk of adverse events for patients with difficult biliary access: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Medicine (Baltimore), 2018, 97(36): e12213.
|
10. |
Sundaralingam P, Masson P, Bourke MJ. Early precut sphincterotomy does not increase risk during endoscopic retrograde cholangiopancreatography in patients with difficult biliary access: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol, 2015, 13(10): 1722-1729.
|
11. |
Keswani RN, Qumseya BJ, O'Dwyer LC, et al. Association between endoscopist and center endoscopic retrograde cholangiopancreatography volume with procedure success and adverse outcomes: a systematic review and meta-analysis. Clin Gastroenterol Hepatol, 2017, 15(12): 1866-1875.
|
12. |
Lee HJ, Cho CM, Heo J, et al. Impact of hospital volume and the experience of endoscopist on adverse events related to endoscopic retrograde cholangiopancreatography: a prospective observational study. Gut Liver, 2020, 14(2): 257-264.
|
13. |
Luo H, Zhao L, Leung J, et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet, 2016, 387(10035): 2293-2301.
|
14. |
Fakoya AOJ, Omenyi P, Anthony P, et al. Stevens-johnson syndrome and toxic epidermal necrolysis; extensive review of reports of drug-induced etiologies, and possible therapeutic modalities. Open Access Maced J Med Sci, 2018, 6(4): 730-738.
|
15. |
Vostinaru O. Adverse effects and drug interactions of the non-steroidal anti-inflammatory drugs. In Al-kaf AGA, ed. Nonsteroidal antiinflammatory drugs. Londen: InTech, 2017.
|
16. |
Patai Á, Solymosi N, Patai AV. Does rectal indomethacin given for prevention of post-ERCP pancreatitis increase bleeding after biliary endoscopic sphincterotomy or cardiovascular mortality?: Post hoc analysis using prospective clinical trial data. Medicine (Baltimore), 2014, 93(26): e159.
|
17. |
Park CH, Paik WH, Park ET, et al. Aggressive intravenous hydration with lactated Ringer's solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial. Endoscopy, 2018, 50(4): 378-385.
|
18. |
Ding J, Jin X, Pan Y, et al. Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials. PLoS One, 2013, 8(10).
|
19. |
Sotoudehmanesh R, Eloubeidi MA, Asgari AA, et al. A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis. Am J Gastroenterol, 2014, 109(6): 903-909.
|
20. |
Zhang ZF, Yang N, Zhao G, et al. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis. Chin Med J (Engl), 2010, 123(18): 2600-2606.
|
21. |
Park KT, Kang DH, Choi CW, et al. Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients? Pancreas, 2011, 40(8): 1215-1219.
|
22. |
Xu LH, Qian JB, Gu LG, et al. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla: Prevention of PEP by epinephrine spray. J Gastroenterol Hepatol, 2011, 26(7): 1139-1144.
|
23. |
Matsushita M, Takakuwa H, Shimeno N, et al. Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol, 2009, 44(1): 71-75.
|
24. |
Ito K, Fujita N, Kanno A, et al. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study. Intern Med, 2011, 50(24): 2927-2932.
|
25. |
Afghani E, Akshintala VS, Khashab MA, et al. 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. Endoscopy, 2014, 46(7): 573-580.
|
26. |
Minakari M, Sebghatollahi V, Sattari M, et al. Serum amylase and lipase levels for prediction of postendoscopic retrograde cholangiopancreatography pancreatitis. J Res Med Sci, 2018, 23: 54.
|
27. |
Karjula H, Nordblad Schmidt P, Mäkelä J, et al. Prophylactic pancreatic duct stenting in severe acute necrotizing pancreatitis: a prospective randomized study. Endoscopy, 2019, 51(11): 1027-1034.
|
28. |
Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci, 2018, 25(1): 41-54.
|
29. |
Thosani N, Zubarik RS, Kochar R, et al. Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP. Endoscopy, 2016, 48(5): 424-431.
|
30. |
Othman MO, Guerrero R, Elhanafi S, et al. A prospective study of the risk of bacteremia in directed cholangioscopic examination of the common bile duct. Gastrointest Endosc, 2016, 83(1): 151-157.
|
31. |
Thomas S, Patel RP, Oto A. Resolution of pneumobilia as a predictor of biliary stent occlusion. Clin Imaging, 2015, 39(4): 650-653.
|
32. |
Reiner CS, Merkle EM, Bashir MR, et al. MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography? AJR Am J Roentgenol, 2013, 201(1): W49-W56.
|
33. |
Lin WC, Lin HH, Hung CY, et al. Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding. PLoS One, 2017, 12(5): e0177449.
|
34. |
Oren A, Breumelhof R, Timmer R, et al. Abnormal clotting parameters before therapeutic ERCP: do they predict major bleeding? Eur J Gastroenterol Hepatol, 1999, 11(10): 1093-1097.
|
35. |
Adike A, Al-Qaisi M, Baffy NJ, et al. International normalized ratio does not predict gastrointestinal bleeding after endoscopic retrograde cholangiopancreatography in patients with cirrhosis. Gastroenterology Res, 2017, 10(3): 177-181.
|
36. |
Mangiavillano B, Montale A, Frazzoni L, et al. Endoscopic biliary self-expandable metallic stent in malignant biliary obstruction with or without sphincterotomy: systematic review and meta-analysis. Endosc Int Open, 2019, 7(1): E26-E35.
|
37. |
Sawas T, Arwani N, Al Halabi S, et al. Sphincterotomy with endoscopic biliary drainage for severe acute cholangitis: a meta-analysis. Endosc Int Open, 2017, 5(2): E103-E109.
|
38. |
Leung WK, But DY, Wong SY, et al. Prevention of post-sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial. J Dig Dis, 2018, 19(6): 369-376.
|
39. |
Cirocchi R, Kelly MD, Griffiths EA, et al. A systematic review of the management and outcome of ERCP related duodenal perforations using a standardized classification system. Surgeon, 2017, 15(6): 379-387.
|
40. |
Verlaan T, Voermans RP, van Berge Henegouwen MI, et al. Endoscopic closure of acute perforations of the GI tract: a systematic review of the literature. Gastrointest Endosc, 2015, 82(4): 618-628.
|
41. |
Paspatis GA, Dumonceau JM, Barthet M, et al. Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy, 2014, 46(8): 693-711.
|
42. |
Park BK, Seo JH, Jeon HH, et al. A nationwide population-based study of common bile duct stone recurrence after endoscopic stone removal in Korea. J Gastroenterol, 2018, 53(5): 670-678.
|